Gene · 369
NIH grants1,471
NIH grants whose papers are about the gene, through NIH's grant-paper links.
761 to 780 of 1,471
Download this page as JSON| Grant | Title | ARAF papers | Newest fiscal year |
|---|---|---|---|
| R01GM046383 | Multisite Phosphorylation and M-Phase Regulation | 2 | 2018 |
| U01EB012493 | Point-of care Microfluidics for Early Detection of Cancer | 2 | 2018 |
| U10CA180866 | Network Lead Academic Participating Site Grant from the Roswell Cancer Inst. | 2 | 2018 |
| F30DA038954 | Identifying distinct striatonigral and striatopallidal disturbances | 1 | 2018 |
| F31CA216965 | Breaking the paradigm: RhoA as a tumor suppressor in cancer | 1 | 2018 |
| F31ES026471 | Studies of mTORC2 signaling in non-melanoma skin cancer | 1 | 2018 |
| F32CA200313 | K-Ras mutant-specific vulnerabilities for novel pancreatic cancer therapies | 1 | 2018 |
| F32CA221005 | Targeting CDK4/6 for pancreatic cancer treatment | 1 | 2018 |
| K08CA181475 | Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods | 1 | 2018 |
| K08DE024774 | Functionalizing recurrent FAT1 mutations and deletions in oral cancer | 1 | 2018 |
| K08NS083732 | Overcoming apoptotic resistance in glioblastoma by CP-d/n-ATF5, a novel tumor spe | 1 | 2018 |
| K22CA188181 | Roles of Spartan in translesion synthesis and UV-induced carcinogenesis | 1 | 2018 |
| K99CA207855 | The role of CADM1 in malignant melanoma | 1 | 2018 |
| P01CA094060 | Program Project in Models of Breast Cancer | 1 | 2018 |
| P01CA104838 | Cancer cell adaptation to metabolic stress | 1 | 2018 |
| P30AI078498 | University of Rochester Center for AIDS Research | 1 | 2018 |
| P30AR057235 | Core Center for Musculoskeletal Biology and Medicine | 1 | 2018 |
| P50AG016574 | Mayo Alzheimer's Disease Research Center | 1 | 2018 |
| P50CA172012 | SPORE in Thyroid Cancer | 1 | 2018 |
| P50GM085273 | Center for Spatiotemporal Modeling of Cell Signaling | 1 | 2018 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/grants?page=39